Skip to content

Study · In vitro (cells) · rat · 1993

5 results

Histamine release on rat pleural and peritoneal mast cells elicited by human GRF(1-29)NH2.

Estévez MD, Botana MA, Arnáez E, Vieytes MR, Botana LM

International archives of allergy and immunology1 Jan 1993Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    Human GRF(1-29)NH2 elicited histamine release from rat pleural and peritoneal mast cells.

    In plain wordsIn rat cells, human GRF(1-29)NH2 made mast cells release histamine.

    Peptide
    Sermorelin
    Outcome
    IncreaseHistamine release
    Study

    ratn: not reported in source

    rat peritoneal and pleural mast cells
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Title
    Histamine release on rat pleural and peritoneal mast cells elicited by human GRF(1-29)NH2.
  2. 02LabIn vitro (cells)Mechanism

    GRF-elicited secretion from rat mast cells was temperature dependent and optimal at 37 degrees C.

    In plain wordsIn rat cells, GRF-triggered histamine release depended on temperature and was best at 37 degrees C.

    Peptide
    Sermorelin
    Outcome
    Not applicableTemperature dependence of secretion
    Study

    ratn: not reported in source

    rat peritoneal and pleural mast cells
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The secretion is temperature dependent, the release being optimal at 37 degrees C
  3. 03LabIn vitro (cells)Mechanism

    Activation by GRF was similar in pleural and peritoneal rat mast cells.

    In plain wordsIn rat cells, GRF activated pleural and peritoneal mast cells in a similar way.

    Peptide
    Sermorelin
    Outcome
    No significant changeActivation of pleural versus peritoneal mast cells
    Study

    ratn: not reported in source

    rat peritoneal and pleural mast cells
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The activation of pleural and peritoneal mast cells is similar

Studies that did not test the peptide alone2

In this study, Sermorelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Sermorelin.

  1. 04LabNot a test of Sermorelin aloneIn vitro (cells)Mechanism

    Antimycin A inhibited GRF-elicited secretion from rat mast cells.

    In plain wordsIn rat cells, antimycin A reduced histamine release triggered by GRF.

    Peptide
    Sermorelin
    Outcome
    DecreaseGRF-elicited secretion after antimycin A
    Study

    ratn: not reported in source

    rat peritoneal and pleural mast cells
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    and it can be inhibited with antimycin A.

    In this study, Sermorelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Sermorelin.

  2. 05LabNot a test of Sermorelin aloneIn vitro (cells)Mechanism

    Purification with Percoll slightly inhibited the GRF-induced activation of both pleural and peritoneal rat mast cells.

    In plain wordsIn rat cells, purifying the cells with Percoll slightly lowered their response to GRF.

    Peptide
    Sermorelin
    Outcome
    DecreaseEffect of Percoll purification on activation
    Study

    ratn: not reported in source

    rat peritoneal and pleural mast cells
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    but there is a slight inhibition for both populations after purification with Percoll.

    In this study, Sermorelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Sermorelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 10:21 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.